In individuals with resistant and refractory chronic myeloid leukemia.

The data confirm strong clinical proof hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in pretreated sufferers with CML heavily, including people that have the T315I mutation of the prospective protein, BCR-ABL. The data are being presented this afternoon at the 46th Annual Achieving of the American Culture of Clinical Oncology being kept in Chicago, IL. Fifty-three of the patients possess resistant and refractory CML or Philadelphia-chromosome positive severe lymphoblastic leukemia . Ninety-four % of the 53 patients have already been treated with, and were resistant to, at least two of the available first-line and second-collection tyrosine kinase inhibitors for CML.It makes sense that kids, whose brains are developing rapidly, should not be hitting their heads over and over again, said lead author Julie Stamm, who conducted the study as part of her doctoral dissertation at Boston University’s Center for the analysis of Traumatic Encephalopathy. This study helps that idea and suggests that there may be later-life consequences connected with experiencing these repeated hits during childhood, said Stamm, who’s today a postdoctoral researcher in radiology at the University of Wisconsin School of Medicine and Public Health. However, the existing study could not prove a cause-and-effect romantic relationship between playing soccer at a young age and the brain changes seen later on in life.

You Might Also Like